Download Zipped Introduced WordPerfect HB0052.ZIP
[Status][Bill Documents][Fiscal Note][Bills Directory]

H.B. 52

             1     

CONTROLLED SUBSTANCES REVISIONS

             2     
2013 GENERAL SESSION

             3     
STATE OF UTAH

             4     
Chief Sponsor: Paul Ray

             5     
Senate Sponsor: Allen M. Christensen

             6     
             7      LONG TITLE
             8      Committee Note:
             9          The Health and Human Services Interim Committee recommended this bill.
             10      General Description:
             11          This bill modifies the Utah Controlled Substances Act by adding controlled substances
             12      and making a technical correction.
             13      Highlighted Provisions:
             14          This bill:
             15          .    adds new "spice" and "bath salts" analogs to the list of unscheduled controlled
             16      substances; and
             17          .    makes a technical spelling correction of a substance listed in the scheduled
             18      controlled substances.
             19      Money Appropriated in this Bill:
             20          None
             21      Other Special Clauses:
             22          None
             23      Utah Code Sections Affected:
             24      AMENDS:
             25          58-37-4, as last amended by Laws of Utah 2012, Chapter 297
             26          58-37-4.2, as last amended by Laws of Utah 2012, Chapter 297
             27     


             28      Be it enacted by the Legislature of the state of Utah:
             29          Section 1. Section 58-37-4 is amended to read:
             30           58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
             31      required -- Specific substances included in schedules.
             32          (1) There are established five schedules of controlled substances known as Schedules I,
             33      II, III, IV, and V which consist of substances listed in this section.
             34          (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
             35      the official name, common or usual name, chemical name, or brand name designated:
             36          (a) Schedule I:
             37          (i) Unless specifically excepted or unless listed in another schedule, any of the
             38      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             39      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             40      chemical designation:
             41          (A) Acetyl-alpha-methylfentanyl
             42      (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
             43          (B) Acetylmethadol;
             44          (C) Allylprodine;
             45          (D) Alphacetylmethadol, except levo-alphacetylmethadol also known as
             46      levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
             47          (E) Alphameprodine;
             48          (F) Alphamethadol;
             49          (G) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
             50      propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
             51          (H) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
             52      piperidinyl]-N-phenylpropanamide);
             53          (I) Benzylpiperazine;
             54          (J) Benzethidine;
             55          (K) Betacetylmethadol;
             56          (L) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
             57      piperidinyl]-N-phenylpropanamide);
             58          (M) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-


             59      phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
             60          (N) Betameprodine;
             61          (O) Betamethadol;
             62          (P) Betaprodine;
             63          (Q) Clonitazene;
             64          (R) Dextromoramide;
             65          (S) Diampromide;
             66          (T) Diethylthiambutene;
             67          (U) Difenoxin;
             68          (V) Dimenoxadol;
             69          (W) Dimepheptanol;
             70          (X) Dimethylthiambutene;
             71          (Y) Dioxaphetyl butyrate;
             72          (Z) Dipipanone;
             73          (AA) Ethylmethylthiambutene;
             74          (BB) Etonitazene;
             75          (CC) Etoxeridine;
             76          (DD) Furethidine;
             77          (EE) Hydroxypethidine;
             78          (FF) Ketobemidone;
             79          (GG) Levomoramide;
             80          (HH) Levophenacylmorphan;
             81          (II) Morpheridine;
             82          (JJ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
             83          (KK) Noracymethadol;
             84          (LL) Norlevorphanol;
             85          (MM) Normethadone;
             86          (NN) Norpipanone;
             87          (OO) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
             88      propanamide;
             89          (PP) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);


             90          (QQ) Phenadoxone;
             91          (RR) Phenampromide;
             92          (SS) Phenomorphan;
             93          (TT) Phenoperidine;
             94          (UU) Piritramide;
             95          (VV) Proheptazine;
             96          (WW) Properidine;
             97          (XX) Propiram;
             98          (YY) Racemoramide;
             99          (ZZ) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
             100          (AAA) Tilidine;
             101          (BBB) Trimeperidine;
             102          (CCC) 3-methylfentanyl, including the optical and geometric isomers
             103      (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
             104          (DDD) 3-methylthiofentanyl
             105      (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
             106          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             107      following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
             108      salts, isomers, and salts of isomers is possible within the specific chemical designation:
             109          (A) Acetorphine;
             110          (B) Acetyldihydrocodeine;
             111          (C) Benzylmorphine;
             112          (D) Codeine methylbromide;
             113          (E) Codeine-N-Oxide;
             114          (F) Cyprenorphine;
             115          (G) Desomorphine;
             116          (H) Dihydromorphine;
             117          (I) Drotebanol;
             118          (J) Etorphine (except hydrochloride salt);
             119          (K) Heroin;
             120          (L) Hydromorphinol;


             121          (M) Methyldesorphine;
             122          (N) Methylhydromorphine;
             123          (O) Morphine methylbromide;
             124          (P) Morphine methylsulfonate;
             125          (Q) Morphine-N-Oxide;
             126          (R) Myrophine;
             127          (S) Nicocodeine;
             128          (T) Nicomorphine;
             129          (U) Normorphine;
             130          (V) Pholcodine; and
             131          (W) Thebacon.
             132          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             133      compound, mixture, or preparation which contains any quantity of the following hallucinogenic
             134      substances, or which contains any of their salts, isomers, and salts of isomers when the
             135      existence of the salts, isomers, and salts of isomers is possible within the specific chemical
             136      designation; as used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and
             137      geometric isomers:
             138          (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
             139      .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
             140          (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
             141      4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
             142          (C) 4-bromo-2,5-[dimethoxypenethylamine]dimethoxyphenethylamine, some trade or
             143      other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B,
             144      Nexus;
             145          (D) 2,5-dimethoxyamphetamine, some trade or other names:
             146      2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
             147          (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
             148          (F) 4-methoxyamphetamine, some trade or other names:
             149      4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
             150          (G) 5-methoxy-3,4-methylenedioxyamphetamine;
             151          (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:


             152      4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
             153          (I) 3,4-methylenedioxy amphetamine;
             154          (J) 3,4-methylenedioxymethamphetamine (MDMA);
             155          (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
             156      alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
             157          (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
             158      N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
             159          (M) 3,4,5-trimethoxy amphetamine;
             160          (N) Bufotenine, some trade and other names:
             161      3-(.-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
             162      N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
             163          (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
             164          (P) Dimethyltryptamine, some trade or other names: DMT;
             165          (Q) Ibogaine, some trade and other names:
             166      7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
             167      [5,4-b] indole; Tabernanthe iboga;
             168          (R) Lysergic acid diethylamide;
             169          (S) Marijuana;
             170          (T) Mescaline;
             171          (U) Parahexyl, some trade or other names:
             172      3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
             173          (V) Peyote, meaning all parts of the plant presently classified botanically as
             174      Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
             175      any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
             176      preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
             177          (W) N-ethyl-3-piperidyl benzilate;
             178          (X) N-methyl-3-piperidyl benzilate;
             179          (Y) Psilocybin;
             180          (Z) Psilocyn;
             181          (AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
             182      (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis


             183      plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
             184      and their isomers with similar chemical structure and pharmacological activity to those
             185      substances contained in the plant, such as the following: .1 cis or trans tetrahydrocannabinol,
             186      and their optical isomers .6 cis or trans tetrahydrocannabinol, and their optical isomers .3,4
             187      cis or trans tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
             188      substances is not internationally standardized, compounds of these structures, regardless of
             189      numerical designation of atomic positions covered;
             190          (BB) Ethylamine analog of phencyclidine, some trade or other names:
             191      N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
             192      N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
             193          (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
             194      1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
             195          (DD) Thiophene analog of phencyclidine, some trade or other names:
             196      1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
             197          (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
             198          (iv) Unless specifically excepted or unless listed in another schedule, any material
             199      compound, mixture, or preparation which contains any quantity of the following substances
             200      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             201      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             202      specific chemical designation:
             203          (A) Mecloqualone; and
             204          (B) Methaqualone.
             205          (v) Any material, compound, mixture, or preparation containing any quantity of the
             206      following substances having a stimulant effect on the central nervous system, including their
             207      salts, isomers, and salts of isomers:
             208          (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
             209      4,5-dihydro-5-phenyl-2-oxazolamine;
             210          (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
             211      alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
             212          (C) Fenethylline;
             213          (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;


             214      alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
             215      alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
             216      methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
             217      optical isomers;
             218          (E) (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
             219          (F) N-ethylamphetamine; and
             220          (G) N,N-dimethylamphetamine, also known as
             221      N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
             222          (vi) Any material, compound, mixture, or preparation which contains any quantity of
             223      the following substances, including their optical isomers, salts, and salts of isomers, subject to
             224      temporary emergency scheduling:
             225          (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
             226          (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
             227          (vii) Unless specifically excepted or unless listed in another schedule, any material,
             228      compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
             229      (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
             230          (b) Schedule II:
             231          (i) Unless specifically excepted or unless listed in another schedule, any of the
             232      following substances whether produced directly or indirectly by extraction from substances of
             233      vegetable origin, or independently by means of chemical synthesis, or by a combination of
             234      extraction and chemical synthesis:
             235          (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
             236      opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
             237      and their respective salts, but including:
             238          (I) Raw opium;
             239          (II) Opium extracts;
             240          (III) Opium fluid;
             241          (IV) Powdered opium;
             242          (V) Granulated opium;
             243          (VI) Tincture of opium;
             244          (VII) Codeine;


             245          (VIII) Ethylmorphine;
             246          (IX) Etorphine hydrochloride;
             247          (X) Hydrocodone;
             248          (XI) Hydromorphone;
             249          (XII) Metopon;
             250          (XIII) Morphine;
             251          (XIV) Oxycodone;
             252          (XV) Oxymorphone; and
             253          (XVI) Thebaine;
             254          (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
             255      identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
             256      substances may not include the isoquinoline alkaloids of opium;
             257          (C) Opium poppy and poppy straw;
             258          (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
             259      any salt, compound, derivative, or preparation which is chemically equivalent or identical with
             260      any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
             261      and salts of isomers and derivatives, whether derived from the coca plant or synthetically
             262      produced, except the substances may not include decocainized coca leaves or extraction of coca
             263      leaves, which extractions do not contain cocaine or ecgonine; and
             264          (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
             265      liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
             266          (ii) Unless specifically excepted or unless listed in another schedule, any of the
             267      following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
             268      ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
             269      chemical designation, except dextrorphan and levopropoxyphene:
             270          (A) Alfentanil;
             271          (B) Alphaprodine;
             272          (C) Anileridine;
             273          (D) Bezitramide;
             274          (E) Bulk dextropropoxyphene (nondosage forms);
             275          (F) Carfentanil;


             276          (G) Dihydrocodeine;
             277          (H) Diphenoxylate;
             278          (I) Fentanyl;
             279          (J) Isomethadone;
             280          (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
             281      levomethadyl acetate, or LAAM;
             282          (L) Levomethorphan;
             283          (M) Levorphanol;
             284          (N) Metazocine;
             285          (O) Methadone;
             286          (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
             287          (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
             288      acid;
             289          (R) Pethidine (meperidine);
             290          (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
             291          (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
             292          (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
             293          (V) Phenazocine;
             294          (W) Piminodine;
             295          (X) Racemethorphan;
             296          (Y) Racemorphan;
             297          (Z) Remifentanil; and
             298          (AA) Sufentanil.
             299          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             300      compound, mixture, or preparation which contains any quantity of the following substances
             301      having a stimulant effect on the central nervous system:
             302          (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
             303          (B) Methamphetamine, its salts, isomers, and salts of its isomers;
             304          (C) Phenmetrazine and its salts; and
             305          (D) Methylphenidate.
             306          (iv) Unless specifically excepted or unless listed in another schedule, any material,


             307      compound, mixture, or preparation which contains any quantity of the following substances
             308      having a depressant effect on the central nervous system, including its salts, isomers, and salts
             309      of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
             310      specific chemical designation:
             311          (A) Amobarbital;
             312          (B) Glutethimide;
             313          (C) Pentobarbital;
             314          (D) Phencyclidine;
             315          (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
             316      1-piperidinocyclohexanecarbonitrile (PCC); and
             317          (F) Secobarbital.
             318          (v) (A) Unless specifically excepted or unless listed in another schedule, any material,
             319      compound, mixture, or preparation which contains any quantity of Phenylacetone.
             320          (B) Some of these substances may be known by trade or other names:
             321      phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
             322          (vi) Nabilone, another name for nabilone:
             323      (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
             324      6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
             325          (c) Schedule III:
             326          (i) Unless specifically excepted or unless listed in another schedule, any material,
             327      compound, mixture, or preparation which contains any quantity of the following substances
             328      having a stimulant effect on the central nervous system, including its salts, isomers whether
             329      optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
             330      and salts of isomers is possible within the specific chemical designation:
             331          (A) Those compounds, mixtures, or preparations in dosage unit form containing any
             332      stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
             333      listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
             334      Code of Federal Regulations, and any other drug of the quantitive composition shown in that
             335      list for those drugs or which is the same except that it contains a lesser quantity of controlled
             336      substances;
             337          (B) Benzphetamine;


             338          (C) Chlorphentermine;
             339          (D) Clortermine; and
             340          (E) Phendimetrazine.
             341          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             342      compound, mixture, or preparation which contains any quantity of the following substances
             343      having a depressant effect on the central nervous system:
             344          (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
             345      pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
             346      which are not listed in any schedule;
             347          (B) Any suppository dosage form containing amobarbital, secobarbital, or
             348      pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
             349      Administration for marketing only as a suppository;
             350          (C) Any substance which contains any quantity of a derivative of barbituric acid or any
             351      salt of any of them;
             352          (D) Chlorhexadol;
             353          (E) Buprenorphine;
             354          (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
             355      isomers, and salts of isomers, for which an application is approved under the federal Food,
             356      Drug, and Cosmetic Act, Section 505;
             357          (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
             358      . -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
             359          (H) Lysergic acid;
             360          (I) Lysergic acid amide;
             361          (J) Methyprylon;
             362          (K) Sulfondiethylmethane;
             363          (L) Sulfonethylmethane;
             364          (M) Sulfonmethane; and
             365          (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a
             366      tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
             367      2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
             368      4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,


             369      flupyrazapon.
             370          (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
             371      U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
             372      (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
             373      (-)-delta-9-(trans)-tetrahydrocannabinol.
             374          (iv) Nalorphine.
             375          (v) Unless specifically excepted or unless listed in another schedule, any material,
             376      compound, mixture, or preparation containing limited quantities of any of the following
             377      narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
             378          (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             379      milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
             380      opium;
             381          (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
             382      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             383      therapeutic amounts;
             384          (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             385      than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
             386      alkaloid of opium;
             387          (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             388      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             389      recognized therapeutic amounts;
             390          (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
             391      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             392      therapeutic amounts;
             393          (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
             394      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             395      recognized therapeutic amounts;
             396          (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
             397      more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             398      recognized therapeutic amounts; and
             399          (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with


             400      one or more active, non-narcotic ingredients in recognized therapeutic amounts.
             401          (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids
             402      including any of the following or any isomer, ester, salt, or derivative of the following that
             403      promotes muscle growth:
             404          (A) Boldenone;
             405          (B) Chlorotestosterone (4-chlortestosterone);
             406          (C) Clostebol;
             407          (D) Dehydrochlormethyltestosterone;
             408          (E) Dihydrotestosterone (4-dihydrotestosterone);
             409          (F) Drostanolone;
             410          (G) Ethylestrenol;
             411          (H) Fluoxymesterone;
             412          (I) Formebulone (formebolone);
             413          (J) Mesterolone;
             414          (K) Methandienone;
             415          (L) Methandranone;
             416          (M) Methandriol;
             417          (N) Methandrostenolone;
             418          (O) Methenolone;
             419          (P) Methyltestosterone;
             420          (Q) Mibolerone;
             421          (R) Nandrolone;
             422          (S) Norethandrolone;
             423          (T) Oxandrolone;
             424          (U) Oxymesterone;
             425          (V) Oxymetholone;
             426          (W) Stanolone;
             427          (X) Stanozolol;
             428          (Y) Testolactone;
             429          (Z) Testosterone; and
             430          (AA) Trenbolone.


             431          (vii) Anabolic steroids expressly intended for administration through implants to cattle
             432      or other nonhuman species, and approved by the Secretary of Health and Human Services for
             433      use, may not be classified as a controlled substance.
             434          (d) Schedule IV:
             435          (i) Unless specifically excepted or unless listed in another schedule, any material,
             436      compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
             437      less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
             438          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             439      compound, mixture, or preparation which contains any quantity of the following substances,
             440      including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
             441      salts of isomers is possible within the specific chemical designation:
             442          (A) Alprazolam;
             443          (B) Barbital;
             444          (C) Bromazepam;
             445          (D) Butorphanol;
             446          (E) Camazepam;
             447          (F) Carisoprodol;
             448          (G) Chloral betaine;
             449          (H) Chloral hydrate;
             450          (I) Chlordiazepoxide;
             451          (J) Clobazam;
             452          (K) Clonazepam;
             453          (L) Clorazepate;
             454          (M) Clotiazepam;
             455          (N) Cloxazolam;
             456          (O) Delorazepam;
             457          (P) Diazepam;
             458          (Q) Dichloralphenazone;
             459          (R) Estazolam;
             460          (S) Ethchlorvynol;
             461          (T) Ethinamate;


             462          (U) Ethyl loflazepate;
             463          (V) Fludiazepam;
             464          (W) Flunitrazepam;
             465          (X) Flurazepam;
             466          (Y) Halazepam;
             467          (Z) Haloxazolam;
             468          (AA) Ketazolam;
             469          (BB) Loprazolam;
             470          (CC) Lorazepam;
             471          (DD) Lormetazepam;
             472          (EE) Mebutamate;
             473          (FF) Medazepam;
             474          (GG) Meprobamate;
             475          (HH) Methohexital;
             476          (II) Methylphenobarbital (mephobarbital);
             477          (JJ) Midazolam;
             478          (KK) Nimetazepam;
             479          (LL) Nitrazepam;
             480          (MM) Nordiazepam;
             481          (NN) Oxazepam;
             482          (OO) Oxazolam;
             483          (PP) Paraldehyde;
             484          (QQ) Pentazocine;
             485          (RR) Petrichloral;
             486          (SS) Phenobarbital;
             487          (TT) Pinazepam;
             488          (UU) Prazepam;
             489          (VV) Quazepam;
             490          (WW) Temazepam;
             491          (XX) Tetrazepam;
             492          (YY) Triazolam;


             493          (ZZ) Zaleplon; and
             494          (AAA) Zolpidem.
             495          (iii) Any material, compound, mixture, or preparation of fenfluramine which contains
             496      any quantity of the following substances, including its salts, isomers whether optical, position,
             497      or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
             498      isomers is possible.
             499          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             500      compound, mixture, or preparation which contains any quantity of the following substances
             501      having a stimulant effect on the central nervous system, including its salts, isomers whether
             502      optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
             503      isomers, and salts of isomers is possible within the specific chemical designation:
             504          (A) Cathine ((+)-norpseudoephedrine);
             505          (B) Diethylpropion;
             506          (C) Fencamfamine;
             507          (D) Fenproprex;
             508          (E) Mazindol;
             509          (F) Mefenorex;
             510          (G) Modafinil;
             511          (H) Pemoline, including organometallic complexes and chelates thereof;
             512          (I) Phentermine;
             513          (J) Pipradrol;
             514          (K) Sibutramine; and
             515          (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
             516          (v) Unless specifically excepted or unless listed in another schedule, any material,
             517      compound, mixture, or preparation which contains any quantity of dextropropoxyphene
             518      (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
             519          (e) Schedule V: Any compound, mixture, or preparation containing any of the
             520      following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous
             521      base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
             522      sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
             523      qualities other than those possessed by the narcotic drug alone:


             524          (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
             525          (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
             526      grams;
             527          (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
             528      grams;
             529          (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
             530      atropine sulfate per dosage unit;
             531          (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
             532          (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
             533      atropine sulfate per dosage unit; and
             534          (vii) unless specifically exempted or excluded or unless listed in another schedule, any
             535      material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
             536      effect on the central nervous system, including its salts, isomers, and salts of isomers.
             537          Section 2. Section 58-37-4.2 is amended to read:
             538           58-37-4.2. Listed controlled substances.
             539          The following substances, their analogs, homologs, and synthetic equivalents are listed
             540      controlled substances:
             541          (1) AB-001;
             542          (2) AKB48;
             543          (3) alpha-Pyrrolidinovalerophenone (alpha-PVP);
             544          [(1)] (4) AM-694; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone;
             545          (5) AM-1248;
             546          [(2)] (6) AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;
             547          (7) AM-2233;
             548          (8) AM-679;
             549          (9) A796,260;
             550          (10) Butylone;
             551          [(3)] (11) CP 47,497 and its C6, C8, and C9 homologs;
             552      2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol;
             553          (12) Diisopropyltryptamine (DiPT);
             554          (13) Ethylone;


             555          (14) Fluoroisocathinone;
             556          (15) Fluoromethamphetamine;
             557          [(4)] (16) Fluoromethcathinone;
             558          [(5)] (17) HU-210;
             559      (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)
             560      -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
             561          [(6)] (18) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
             562      methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
             563          [(7)] (19) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;
             564          [(8)] (20) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as
             565      1-Pentyl-3-(1-naphthoyl)indole};
             566          [(9)] (21) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;
             567          [(10)] (22) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as
             568      1-Butyl-3-(1-naphthoyl)indole};
             569          [(11)] (23) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;
             570          [(12)] (24) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);
             571          [(13)] (25) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;
             572          [(14)] (26) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;
             573          [(15)] (27) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;
             574          [(16)] (28) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;
             575          [(17)] (29) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;
             576          [(18)] (30) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;
             577          (31) MAM-2201;
             578          (32) Methoxetamine;
             579          (33) Naphyrone;
             580          (34) Pentedrone;
             581          (35) Pentylone;
             582          [(19)] (36) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;
             583          [(20)] (37) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also
             584      known as BTW-8 and SR-18};
             585          (38) STS-135;


             586          (39) UR-144;
             587          (40) UR-144 N-(5-chloropentyl) analog;
             588          (41) XLR11;
             589          (42) 2C-C;
             590          (43) 2C-D;
             591          (44) 2C-E;
             592          (45) 2C-H;
             593          (46) 2C-I;
             594          (47) 2C-N;
             595          (48) 2C-P;
             596          (49) 2C-T-2 ;
             597          (50) 2C-T-4 ;
             598          (51) 2NE1;
             599          (52) 25I-NBOMe;
             600          (53) 2,5-Dimethoxy-4-chloroamphetamine (DOC);
             601          [(21)] (54) 4-methylmethcathinone {also known as mephedrone};
             602          [(22)] (55) 3,4-methylenedioxypyrovalerone {also known as MDPV};
             603          [(23)] (56) 3,4-Methylenedioxymethcathinone {also known as methylone}; [and]
             604          [(24)] (57) 4-methoxymethcathinone[.];
             605          (58) 4-Methyl-alpha-pyrrolidinopropiophenone;
             606          (59) 4-Methylethcathinone;
             607          (60) 5-Iodo-2-aminoindane (5-IAI); and
             608          (61) 5-MeO-DALT .




Legislative Review Note
    as of 11-15-12 3:59 PM


Office of Legislative Research and General Counsel


[Bill Documents][Bills Directory]